H. Keilacker

420 total citations
40 papers, 181 citations indexed

About

H. Keilacker is a scholar working on Surgery, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, H. Keilacker has authored 40 papers receiving a total of 181 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Surgery, 23 papers in Genetics and 22 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in H. Keilacker's work include Pancreatic function and diabetes (25 papers), Diabetes and associated disorders (23 papers) and Diabetes Management and Research (17 papers). H. Keilacker is often cited by papers focused on Pancreatic function and diabetes (25 papers), Diabetes and associated disorders (23 papers) and Diabetes Management and Research (17 papers). H. Keilacker collaborates with scholars based in Germany, United States and Poland. H. Keilacker's co-authors include I Rjasanowski, К.-D. Kohnert, W. Besch, Hubert Kolb, F. A. Gries, Sabine Witt, J. Bertrams, B. Kuglin, M. Ziegler and B Ziegler and has published in prestigious journals such as Diabetes Care, Diabetologia and Diabetes Research and Clinical Practice.

In The Last Decade

H. Keilacker

29 papers receiving 174 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Keilacker Germany 7 115 110 104 24 23 40 181
Elbay Aliyev Qatar 6 52 0.5× 44 0.4× 44 0.4× 27 1.1× 14 0.6× 13 121
C Mesturino Italy 4 129 1.1× 99 0.9× 63 0.6× 9 0.4× 63 2.7× 5 183
Margherita Occhipinti Italy 10 92 0.8× 123 1.1× 225 2.2× 76 3.2× 16 0.7× 16 292
Munkhtuya Tumurkhuu Mongolia 5 18 0.2× 49 0.4× 48 0.5× 62 2.6× 9 0.4× 8 122
Rebecka Hjort Sweden 7 120 1.0× 101 0.9× 82 0.8× 22 0.9× 17 0.7× 10 163
Christiaan Van Schravendijk Belgium 11 317 2.8× 271 2.5× 397 3.8× 95 4.0× 33 1.4× 17 507
Martin Haupt‐Jorgensen Denmark 11 144 1.3× 61 0.6× 68 0.7× 114 4.8× 35 1.5× 22 329
Rajotte Rv Canada 10 178 1.5× 185 1.7× 280 2.7× 37 1.5× 7 0.3× 49 313
Kate R. Mueller United States 8 72 0.6× 56 0.5× 159 1.5× 33 1.4× 3 0.1× 17 174
P Chapman United Kingdom 5 22 0.2× 18 0.2× 49 0.5× 39 1.6× 9 0.4× 7 102

Countries citing papers authored by H. Keilacker

Since Specialization
Citations

This map shows the geographic impact of H. Keilacker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Keilacker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Keilacker more than expected).

Fields of papers citing papers by H. Keilacker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Keilacker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Keilacker. The network helps show where H. Keilacker may publish in the future.

Co-authorship network of co-authors of H. Keilacker

This figure shows the co-authorship network connecting the top 25 collaborators of H. Keilacker. A scholar is included among the top collaborators of H. Keilacker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Keilacker. H. Keilacker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hartmann, Katrin, et al.. (2009). Diabetogenic Effects of N-Nitrosomethylurea in Rats. Experimental and Clinical Endocrinology & Diabetes. 92(4). 25–31.
2.
Keilacker, H., et al.. (2009). Autoantibodies against Insulin (IAA), C-peptide (CAA), and Glucagon (GAA) in New-Onset Type 1 Diabetic Patients*). Experimental and Clinical Endocrinology & Diabetes. 95(1). 123–128. 2 indexed citations
3.
Besch, W., et al.. (2009). Measurement of Insulin in Human Sera Using a New RIA Kit. 1. Insulin Determination in the Absence of Insulin Antibodies — Conventional Assay and Micro Modification2). Experimental and Clinical Endocrinology & Diabetes. 90(6). 264–270. 11 indexed citations
4.
Keilacker, H., et al.. (2009). Radioiodination of Peptide Hormones and Immunoglobuline Preparations: Comparison of the Chloramine T and lodogen Method*). Experimental and Clinical Endocrinology & Diabetes. 95(1). 39–46. 6 indexed citations
5.
Kratzsch, Jürgen, et al.. (2009). A Sensitive Sandwich Enzyme Immunoassay for Measurement of Insulin on Microtiter Plates. Experimental and Clinical Endocrinology & Diabetes. 95(2). 229–236. 10 indexed citations
6.
Keilacker, H., et al.. (2009). Measurement Of Insulin in Human Sera Using a New RIA Kit. 2. Determination of Free and Total Insulin — Correlations to Insulin Antibody Levels1). Experimental and Clinical Endocrinology & Diabetes. 90(6). 271–277. 4 indexed citations
7.
Keilacker, H., et al.. (2009). Is there a Relationship between Genetically Determined Haptoglobin Phenotype and Insulin-Dependent Diabetes Mellitus (IDDM)?1). Experimental and Clinical Endocrinology & Diabetes. 83(2). 207–215.
8.
Besch, W., H. Keilacker, К.-D. Kohnert, & M. Ziegler. (2009). Influence of Polyethylene Glycol (PEG) Extraction on the C-Peptide Determination in Sera from Insulin-Dependent Diabetic Patients with Circulating Insulin Antibodies*). Experimental and Clinical Endocrinology & Diabetes. 95(1). 119–122.
9.
Witt, Sandra A., et al.. (2009). Islet Cell Antibodies in Individuals at Increased Risk for IDDM. Experimental and Clinical Endocrinology & Diabetes. 83(2). 192–198.
10.
Keilacker, H., I Rjasanowski, W. Besch, & К.-D. Kohnert. (1995). Autoantibodies to Insulin and to Proinsulin in Type 1 Diabetic Patients and in At-Risk Probands Differentiate Only Little between Both Antigens. Hormone and Metabolic Research. 27(2). 90–94. 16 indexed citations
11.
12.
13.
14.
Keilacker, H., et al.. (1989). Influence of therapy-induced insulin antibodies on glycemic control in type 1 diabetes mellitus.. PubMed. 30(1). 65–6. 1 indexed citations
15.
Witt, Sabine, Harry C. Dietz, B Ziegler, H. Keilacker, & Mario Ziegler. (1988). [Production and use of monoclonal glucagon and insulin antibodies--reduction of pancreatic insulin in rats by treatment with complete Freund's adjuvant].. PubMed. 35. 217–23. 5 indexed citations
16.
Freyse, Ernst‐Joachim, et al.. (1987). The effect of prehepatic insulin administration on alanine flux rates in diabetic dogs. Diabetologia. 30(6). 402–408. 13 indexed citations
17.
Witt, Sabine, et al.. (1984). Mumps Infection and Insulin-dependent Diabetes Mellitus (IDDM). Diabetes Care. 7(2). 170–173. 17 indexed citations
18.
Keilacker, H., et al.. (1980). Radioligand assays — Methods and applications. IV. Uniform regression of hyperbolic and linear radioimmunoassay calibration curves. Journal of Biochemical and Biophysical Methods. 3(4). 225–231. 2 indexed citations
19.
Keilacker, H., et al.. (1978). Effects of sulphydryl reagents on pancreatic glucagon secretion in vitro.. PubMed. 71(3). 286–92. 1 indexed citations
20.
Ziegler, M, et al.. (1977). [Ultramicro radioimmunoassay for insulin using commercial radioimmune reagents (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 18(2). 225–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elbay Aliyev Breakdown of academic impact, for papers by C Mesturino Breakdown of academic impact, for papers by Margherita Occhipinti Breakdown of academic impact, for papers by Munkhtuya Tumurkhuu Breakdown of academic impact, for papers by Rebecka Hjort Breakdown of academic impact, for papers by Christiaan Van Schravendijk Breakdown of academic impact, for papers by Martin Haupt‐Jorgensen Breakdown of academic impact, for papers by Rajotte Rv Breakdown of academic impact, for papers by Kate R. Mueller Breakdown of academic impact, for papers by P Chapman
Rankless by CCL
2026